Overview
Weight loss injectable treatments such as Mounjaro® and Wegovy® are not appropriate for everyone. Certain medical conditions or clinical circumstances can prevent safe prescribing altogether, or may mean MedExpress prescribers need to apply extra caution and closer monitoring during treatment.
Use this article when you want to:
Understand which medical conditions may exclude you from weight loss injectable treatment
Find out when a condition doesn't rule out treatment but requires extra caution instead
Understand how MedExpress prescribers decide clinical suitability for Mounjaro® or Wegovy®
Which Medical Conditions May Prevent Me From Using Weight Loss Injectables?
Weight loss injectables such as Mounjaro® and Wegovy® may not be appropriate if you have:
A history of pancreatitis or pancreatic disease
Severe liver or kidney disease
Unstable mental health conditions that affect your ability to use treatment safely
An eating disorder or other medically unsafe weight-loss behaviour
Any illness where rapid weight change could be harmful
These conditions can increase the risk associated with weight loss injectable treatment, which is why MedExpress prescribers assess them carefully before approving Mounjaro® or Wegovy®.
When Does Prescribing Require Extra Caution Rather Than Full Exclusion?
Some conditions don't automatically prevent treatment, but may mean your MedExpress prescriber needs to apply:
Closer clinical monitoring
Dose adjustment or a slower dose escalation
Consideration of alternative treatments
When reviewing your suitability for Mounjaro® or Wegovy®, MedExpress prescribers assess:
Your overall health status
Any medication interactions
Your ability to follow treatment safely
Why Do These Condition-Specific Exclusions Exist?
Condition-based restrictions on weight loss injectables exist to ensure:
Safe prescribing that's aligned with medical guidance
Reduced risk of complications
Appropriate use of GLP-1 weight-management therapy
Safety remains MedExpress's primary clinical priority when assessing eligibility for Mounjaro® or Wegovy®.